SCHEMBL17702145

SCHEMBL17702145

c1ccc(N(c2ccccc2)c2ccc3c(c2)Oc2cccc4c2c-3cc2ccc(N(c3ccccc3)c3ccc5c(ccc6ccccc65)c3)cc24)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ HIF1A Q16665 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CYP1A2 P05177 2/20 0.35
▸ ERBB2 P04626 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17702146 0.94 MAPK1 (0.35) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702125 0.94 MAPK1 (0.35) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702123 0.94 MAPK1 (0.36) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702161 0.93 MAPK1 (0.33) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702187 0.91 MAPK1 (0.34) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702124 0.90 MAPK1 (0.34) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702296 0.90 MAPK1 (0.33) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702136 0.90 MAPK1 (0.33) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL17702292 0.90 MAPK1 (0.33) ALDH1A1HSD17B10MAPK1HIF1AHPGD
SCHEMBL16805148 0.89 MAPK1 (0.32) ALDH1A1HSD17B10MAPK1HIF1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9741939-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-22 — — US disclosed
US-9741939-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-22 — — US disclosed
US-20160118593-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed
US-20160118593-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118593-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, CCNT1 ALDH1A1 148/4885HSD17B10 1747/4885MAPK1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback